A detailed history of Chase Investment Counsel Corp transactions in Pfizer Inc stock. As of the latest transaction made, Chase Investment Counsel Corp holds 182,784 shares of PFE stock, worth $4.82 Million. This represents 1.79% of its overall portfolio holdings.

Number of Shares
182,784
Holding current value
$4.82 Million
% of portfolio
1.79%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 05, 2024

BUY
$27.7 - $31.39 $5.06 Million - $5.74 Million
182,784 New
182,784 $5.29 Million
Q3 2023

Nov 08, 2023

BUY
$32.09 - $37.51 $740,059 - $865,055
23,062 Added 199.55%
34,619 $1.15 Million
Q2 2023

Jul 28, 2023

BUY
$36.12 - $41.79 $20,227 - $23,402
560 Added 5.09%
11,557 $423,000
Q1 2023

May 04, 2023

BUY
$39.39 - $51.28 $36,553 - $47,587
928 Added 9.22%
10,997 $448,000
Q4 2022

Jan 25, 2023

SELL
$41.75 - $54.5 $75,358 - $98,372
-1,805 Reduced 15.2%
10,069 $515,000
Q2 2022

Jul 26, 2022

BUY
$46.53 - $55.17 $23,497 - $27,860
505 Added 4.44%
11,874 $622,000
Q1 2022

Apr 21, 2022

BUY
$45.75 - $56.69 $31,338 - $38,832
685 Added 6.41%
11,369 $588,000
Q4 2021

Feb 02, 2022

SELL
$41.32 - $61.25 $16,982 - $25,173
-411 Reduced 3.7%
10,684 $630,000
Q3 2021

Nov 04, 2021

SELL
$39.25 - $50.42 $852,706 - $1.1 Million
-21,725 Reduced 66.19%
11,095 $477,000
Q2 2021

Jul 29, 2021

BUY
$35.91 - $40.68 $785,351 - $889,671
21,870 Added 199.73%
32,820 $1.29 Million
Q1 2021

May 06, 2021

BUY
$33.49 - $37.77 $33,992 - $38,336
1,015 Added 10.22%
10,950 $396,000
Q4 2020

Feb 02, 2021

SELL
$33.47 - $42.56 $31,127 - $39,580
-930 Reduced 8.56%
9,935 $365,000
Q3 2020

Nov 03, 2020

SELL
$31.75 - $37.25 $61,722 - $72,414
-1,944 Reduced 15.18%
10,865 $398,000
Q2 2020

Aug 05, 2020

BUY
$30.12 - $36.54 $91,625 - $111,154
3,042 Added 31.15%
12,809 $418,000
Q1 2020

May 08, 2020

BUY
$27.03 - $38.62 $8,244 - $11,779
305 Added 3.22%
9,767 $318,000
Q4 2019

Feb 06, 2020

SELL
$32.92 - $37.36 $362 - $410
-11 Reduced 0.12%
9,462 $370,000
Q3 2019

Oct 29, 2019

BUY
$32.49 - $42.13 $4,743 - $6,150
146 Added 1.57%
9,473 $340,000
Q1 2019

May 03, 2019

BUY
$37.5 - $41.2 $63,675 - $69,957
1,698 Added 22.26%
9,327 $396,000
Q4 2018

Feb 04, 2019

SELL
$38.47 - $43.86 $29,044 - $33,114
-755 Reduced 9.01%
7,629 $333,000
Q3 2018

Nov 01, 2018

BUY
$34.47 - $41.81 $40,295 - $48,875
1,169 Added 16.2%
8,384 $369,000
Q2 2018

Aug 07, 2018

BUY
$32.98 - $35.16 $37,927 - $40,433
1,150 Added 18.96%
7,215 $261,000
Q1 2018

May 07, 2018

SELL
$31.91 - $37.02 $35,420 - $41,092
-1,110 Reduced 15.47%
6,065 $215,000
Q3 2017

Nov 03, 2017

BUY
$31.0 - $34.15 $222,425 - $245,026
7,175
7,175 $256,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $148B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Chase Investment Counsel Corp Portfolio

Follow Chase Investment Counsel Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Chase Investment Counsel Corp, based on Form 13F filings with the SEC.

News

Stay updated on Chase Investment Counsel Corp with notifications on news.